Impacto de la implementación de un modelo de gestión integral de atención de la enfermedad y cuidado coordinado en la población en diálisis en Colombia


Autoria(s): Bunch, Alfonso; Calderón, Juliana; Yamin, Gladis; Vesga, Jasmín; Sanabria, Mauricio
Contribuinte(s)

Gonzalez, Javier

Data(s)

04/09/2016

Resumo

La atención hospitalaria en el costo global de la atención de los pacientes en diálisis es muy importante. Este estudio se realizó con el fin de evaluar resultados posteriores a la implementación de un modelo de gestión de la enfermedad y cuidado coordinado en una red de diálisis en Colombia, evaluando los cambios específicos en las tasas de hospitalización de una cohorte de pacientes renales con dos años de seguimiento. El modelo se enfoca básicamente en mejorar la atención de los pacientes en diálisis protocolizando en el manejo de comorbilidades (diabetes, riesgo cardiovascular, patologías infecciosas) y en el cuidado coordinado entre el tratamiento ambulatorio y hospitalario de los pacientes en diálisis asegurando la continuidad en el proceso de atención de los pacientes. El Estudio observacional analítico de cohortes compuesto por 2 fases una primera cohorte histórica retrospectiva y una segunda con dos cohortes prospectivas, incluyó pacientes mayores de 18 años, con más de 90 días en diálisis, con al menos tres meses de intervención con el modelo de gestión de enfermedad en la red Renal Therapy Services (RTS®). En conclusión, la realización de este estudio, se pudo asociar a la reducción en la atención hospitalaria de pacientes en diálisis y a una menor mortalidad, modelos como este y otras soluciones para mejorar los desenlaces en salud en los pacientes en diálisis deben seguir siendo implementados para aliviar la carga de la enfermedad y reducir los costos de la atención en salud de esta población.

RTS SAS

Centro de Estudios Empresariales para la Perdurabilidad

The end stage kidney disease has become epidemic with prevalence that has been increasing in a progressive way. The cost of treating the chronic kidney disease with dialysis doesn’t only depend on substitutive treatment but in handling the comorbidities and cardiovascular and infectious complications. The hospital care in the global cost of the patient’s treatment within dialysis is very high. Epidemiologic data published in recent years show the frequency of the events and number of hospital days of dialysis patients around the world. This study was made to evaluate subsequent results after the implementation of a disease management and coordinated care program in a dialysis network in Colombia, evaluating specific changes in a cohort of patients before and 2 years after de implementation. The program focuses basically in improving the treatment of dialysis patients by setting protocols in the management of comorbidities (e.g. diabetes, cardiovascular risk, infectious pathologies) and the coordinated care between ambulatory and hospital care. The design was an analytic observational study composed by two phases, a first retrospective historical cohort and a second phase with two prospective cohorts including prevalent patients. The study, showed important results in terms of significant improvement in HbA1c control in diabetic patients and reduction in the use of vascular catheters, also resulted in the reduction of hospitalization rates, hospital days per patient per year and mortality. The implementation of models as the one described could be a way to improve outcomes in dialysis patients and reduce the overall cost of care.

Formato

application/pdf

Identificador

http://repository.urosario.edu.co/handle/10336/12393

Idioma(s)

spa

Publicador

Facultad de administración

Direitos

info:eu-repo/semantics/openAccess

Fonte

instname:Universidad del Rosario

reponame:Repositorio Institucional EdocUR

Acuña Merchan, L. (2016). Situación de la Enfermedad Renal Crónica, Hipetensión y Diabetes en Colombia. 2015. Retrieved from https://cuentadealtocosto.org/site/images/Situaci%C3%B3n_de_la_Enfermedad_Renal_Cr%C3%B3nica_en_Colombia_2015.pdf

Allon, M. (2007). Current Management of Vascular Access. Clinical Journal of the American Society of Nephrology, 2(4), 786–800. http://doi.org/10.2215/CJN.00860207

Assogba, F. G. A., Couchoud, C., Hannedouche, T., Villar, E., Frimat, L., Fagot-Campagna, A., … French Renal Epidemiology and Information Network Registry. (2014). Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011. Diabetologia, 57(4), 718–728. http://doi.org/10.1007/s00125-014-3160-9

Blackstone, E. A., & Fuhr, J. P. (2016). The Economics of Medicare Accountable Care Organizations. American Health & Drug Benefits, 9(1), 11–19.

Bunch, A., Tamer, L., Ardila, F., Laganis, S., Castaño, R., Vesga, J., … Sanabria, M. (2016). Descripción de un modelo de gestión de enfermedad en una población en diálisis en Colombia. Revista Colombiana de Nefrología, 3(1), 5–95.

Chan, K. E., Lazarus, J. M., Wingard, R. L., & Hakim, R. M. (2009). Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge. Kidney International, 76(3), 331–341. http://doi.org/10.1038/ki.2009.199

Cobo, G., Qureshi, A. R., Lindholm, B., & Stenvinkel, P. (2016). C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care. Seminars in Dialysis, 29(1), 7–14. http://doi.org/10.1111/sdi.12440

Coelho, A. P., Sá, H. O., Diniz, J. A., & Dussault, G. (2014). The integrated management for renal replacement therapy in Portugal: IM ESRD in Portugal. Hemodialysis International, 18(1), 175–184. http://doi.org/10.1111/hdi.12064

comprenhensive ESRD Care Model centers for Medicare & Medicaid services. (2016). Retrieved from https://innovation.cms.gov/initiatives/comprehensive-ESRD-care/index.html

Drüeke, T. B., & Parfrey, P. S. (2012). Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s). Kidney International, 82(9), 952–960. http://doi.org/10.1038/ki.2012.270

Duong, U., Mehrotra, R., Molnar, M. Z., Noori, N., Kovesdy, C. P., Nissenson, A. R., & Kalantar-Zadeh, K. (2011). Glycemic Control and Survival in Peritoneal Dialysis Patients with Diabetes Mellitus. Clinical Journal of the American Society of Nephrology, 6(5), 1041–1048. http://doi.org/10.2215/CJN.08921010

Evaluación económica de la hemodiálisis. Análisis de los componentes del coste basado en datos individuales. (2010). Nefrología, (30). http://doi.org/10.3265/Nefrologia.pre2010.Jun.10264

Kessler, M., Zannad, F., Lehert, P., Grunfeld, J. P., Thuilliez, C., Leizorovicz, A., … for the FOSIDIAL Investigators. (2007). Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in Dialysis study. Nephrology Dialysis Transplantation, 22(12), 3573–3579. http://doi.org/10.1093/ndt/gfm417

Kshirsagar, A. V., Hogan, S. L., Mandelkehr, L., & Falk, R. J. (2000). Length of stay and costs for hospitalized hemodialysis patients: nephrologists versus internists. Journal of the American Society of Nephrology: JASN, 11(8), 1526–1533.

Levey, A. S., Beto, J. A., Coronado, B. E., Eknoyan, G., Foley, R. N., Kasiske, B. L., … Wright, J. T. (1998). Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 32(5), 853–906

Maddux, F. (2016). Fresenius Medical Care North America 2016 Annual Medical Report.

Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Tonelli, M., Garg, A. X., … Strippoli, G. F. M. (2010). Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Annals of Internal Medicine, 153(1), 23–33. http://doi.org/10.7326/0003-4819-153-1-201007060-00252

Parfrey, P. S., Foley, R. N., Wittreich, B. H., Sullivan, D. J., Zagari, M. J., & Frei, D. (2005). Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. Journal of the American Society of Nephrology: JASN, 16(7), 2180–2189. http://doi.org/10.1681/ASN.2004121039

Rayner, H. C., Pisoni, R. L., Bommer, J., Canaud, B., Hecking, E., Locatelli, F., … Port, F. K. (2004). Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation, 19(1), 108–120. http://doi.org/10.1093/ndt/gfg483

Ryan, B. L., Brown, J. B., Glazier, R. H., & Hutchison, B. (2016). Examining Primary Healthcare Performance through a Triple Aim Lens. Healthcare Policy = Politiques De Sante, 11(3), 19–31.

Sanabria, M., Rodriguez, K., Sanchez, R., Astudillo, K., Camargo, D., & Bunch, A. (2012). Frecuencia y costos de hospitalización en una población de pacientes en diálisis en Colombia. Rev. Fac Med, 60(4), 253–261

Saran, R., Li, Y., & Robinson, B. (2016). Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases, 67(3 Suppl 1), 211–218

Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., … CHOIR Investigators. (2006). Correction of anemia with epoetin alfa in chronic kidney disease. The New England Journal of Medicine, 355(20), 2085–2098. http://doi.org/10.1056/NEJMoa065485

United States Renal Data System. 2014 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014. (2014). Retrieved from https://www.usrds.org/2014/view/Default.aspx

Valentijn, P. P., Biermann, C., & Bruijnzeels, M. A. (2016). Value-based integrated (renal) care: setting a development agenda for research and implementation strategies. BMC Health Services Research, 16(1). http://doi.org/10.1186/s12913-016-1586-0

Wasse, H. (2008). REDUCING TUNNELED HEMODIALYSIS CATHETER MORBIDITY: Catheter-Related Mortality among ESRD Patients: CATHETER-RELATED MORTALITY. Seminars in Dialysis, 21(6), 547–549. http://doi.org/10.1111/j.1525-139X.2008.00500.x

Wingard, R. L., Pupim, L. B., Krishnan, M., Shintani, A., Ikizler, T. A., & Hakim, R. M. (2007). Early Intervention Improves Mortality and Hospitalization Rates in Incident Hemodialysis Patients: RightStart Program. Clinical Journal of the American Society of Nephrology, 2(6), 1170–1175. http://doi.org/10.2215/CJN.042612

TMAS

Palavras-Chave #616.6 #Insuficiencia Renal #Diálisis Renal #Hospitalización #Dialysis Therapy #Coordinated care #Disease Management #Kidney Disease #Commorbidities #Hospitalization #Hospitalization Rate
Tipo

info:eu-repo/semantics/masterThesis

info:eu-repo/semantics/acceptedVersion